Diseases

Cancer Neurological Disorders Infectious Diseases Autoimmune Diseases Diabetes Chronic Diseases Cardiovascular Diseases Kidney Diseases Infections Neurodegenerative Diseases Respiratory Diseases Endocrine Disorders Viral Infections HIV Bacterial Infections Genetic Disorders Chronic Kidney Disease Bloodborne Diseases Obesity Liver Diseases ALS Antimicrobial Resistance Vector-Borne Diseases Cardiovascular Disease Fungal Infections Muscle Diseases Muscular Disorders Plague Medical Facilities Age-Related Diseases Neurological Diseases Victorian Diseases Brain Tumors RSV (Respiratory Syncytial Virus) Tuberculosis Epilepsy Hepatitis C Alzheimer's Disease Blood Disorders Sexually Transmitted Diseases Lymphatic System Diseases Genetic Diseases Urinary Tract Infections Inflammatory Conditions Vascular Diseases Respiratory Syncytial Virus (RSV) Sleep Apnea Foodborne Illnesses Eye Diseases Skin Diseases Heart Disease Vein Disorders Tick-Borne Diseases Pulmonary Diseases Lymphatic Disorders Neurodegenerative Disorders Endometriosis Inflammatory Diseases Inflammatory Bowel Disease Neuroimmunological Disorders

Fugitive Sought by FBI After Alleged GoFundMe Brain‑Cancer Scam

Intensifying an international manhunt, the FBI listing draws new attention to how medical fundraisers can be abused.

Poll Finds Overwhelming Support for Early Alzheimer’s Diagnosis, Access, and the ASAP Act

Large VA Study Links GLP-1 Drugs to Lower Addiction Risk, Fewer Severe Outcomes

FDA Approves Teclistamab–Daratumumab Combination for Relapsed Multiple Myeloma After One Prior Therapy

Colorectal Cancer Now Leads Cancer Deaths Under 50, Prompting a Screening Push

Willie Anderson Says Kidney Transplant Successful After Surgery This Week

FAK Blockade Reprograms Ovarian Tumor Immunity via Omega-3 Signals in Mice

Alpha-Synuclein Tied to Rapid Alzheimer’s Progression in Women, JAMA Study Finds

Study Identifies tRNA‑Modifying Enzymes as Broad Coronavirus Antiviral Targets

Breakthrough T1D Backs CAR-Treg Beta-Cell Therapy as UChicago Reports PD‑L1 mRNA Results

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug